DAVID BATES to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications DAVID BATES has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
6.987
-
Overrides of clinical decision support alerts in primary care clinics. Stud Health Technol Inform. 2013; 192:923.
Score: 0.388
-
Understanding responses to a renal dosing decision support system in primary care. Stud Health Technol Inform. 2013; 192:931.
Score: 0.388
-
Development of a web-based observational tool for detecting intravenous medication errors with smart infusion pumps. Stud Health Technol Inform. 2013; 192:1102.
Score: 0.388
-
Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care setting. Drug Saf. 2012 Aug 01; 35(8):623-8.
Score: 0.377
-
High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc. 2012 Sep-Oct; 19(5):735-43.
Score: 0.370
-
Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12):1211-5.
Score: 0.336
-
Participation in an ambulatory e-pharmacovigilance system. Pharmacoepidemiol Drug Saf. 2010 Sep; 19(9):961-9.
Score: 0.330
-
Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2010 Jan; 25(1):31-8.
Score: 0.312
-
Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc. 2008 Dec; 56(12):2225-33.
Score: 0.292
-
Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc. 2008 Sep-Oct; 15(5):647-53.
Score: 0.284
-
Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85.
Score: 0.268
-
Adverse drug event detection in a community hospital utilising computerised medication and laboratory data. Drug Saf. 2007; 30(9):817-24.
Score: 0.256
-
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf. 2005 Nov; 14(11):755-67.
Score: 0.236
-
Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):492-8.
Score: 0.217
-
Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004 Aug; 13(4):306-14.
Score: 0.216
-
Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther. 2004 Jan; 75(1):110-22.
Score: 0.208
-
Detecting adverse events using information technology. J Am Med Inform Assoc. 2003 Mar-Apr; 10(2):115-28.
Score: 0.196
-
Using information technology to screen for adverse drug events. Am J Health Syst Pharm. 2002 Dec 01; 59(23):2317-9.
Score: 0.193
-
Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink. JAMA. 2021 10 12; 326(14):1375-1377.
Score: 0.178
-
Drug complications in outpatients. J Gen Intern Med. 2000 Mar; 15(3):149-54.
Score: 0.159
-
Identifying drug safety issues: from research to practice. Int J Qual Health Care. 2000 Feb; 12(1):69-76.
Score: 0.158
-
Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med. 1999 Nov 22; 159(21):2553-60.
Score: 0.156
-
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998 May-Jun; 5(3):305-14.
Score: 0.140
-
High Override Rate for Opioid Drug-allergy Interaction Alerts: Current Trends and Recommendations for Future. Stud Health Technol Inform. 2015; 216:242-6.
Score: 0.111
-
Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993 Jun; 8(6):289-94.
Score: 0.100
-
Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1221-6.
Score: 0.094
-
Preventable adverse drug events and their causes and contributing factors: the analysis of register data. Int J Qual Health Care. 2011 Apr; 23(2):187-97.
Score: 0.085
-
Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr. 2008 Feb; 152(2):225-31.
Score: 0.068
-
Adherence to black box warnings for prescription medications in outpatients. Arch Intern Med. 2006 Feb 13; 166(3):338-44.
Score: 0.060
-
Patient-reported medication symptoms in primary care. Arch Intern Med. 2005 Jan 24; 165(2):234-40.
Score: 0.056
-
Multifaceted approach to reducing preventable adverse drug events. Am J Health Syst Pharm. 2003 Mar 15; 60(6):582-6.
Score: 0.049
-
Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
Score: 0.049
-
Policy and the future of adverse event detection using information technology. J Am Med Inform Assoc. 2003 Mar-Apr; 10(2):226-8.
Score: 0.049
-
Information technology and medication safety: what is the benefit? Qual Saf Health Care. 2002 Sep; 11(3):261-5.
Score: 0.047
-
Heterogeneity of Drug Allergies and Reaction Lists in Two U.S. Health Care Systems' Electronic Health Records. Appl Clin Inform. 2022 05; 13(3):741-751.
Score: 0.046
-
Intelligent Telehealth in Pharmacovigilance: A Future Perspective. Drug Saf. 2022 05; 45(5):449-458.
Score: 0.046
-
Screening for adverse events. J Eval Clin Pract. 1999 Feb; 5(1):23-32.
Score: 0.037
-
The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995 Oct; 21(10):541-8.
Score: 0.029
-
Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc. 2005 Oct; 53(10):1780-9.
Score: 0.015